Mark Sabag - Executive Vice President, International Markets Commercial at Teva Pharmaceutical Industries Ltd

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President, International Markets Commercial
Stock Symbol
TEVA on NYSE, TEVJF on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Mark Sabag - trading volume in the past year for Teva Pharmaceutical Industries Ltd

Holdings reported by Mark Sabag for Teva Pharmaceutical Industries Ltd

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 489K $7.77M $15.90 Mar 5, 2025 Direct
Restricted Share Units 62.9K Mar 5, 2025 Direct Ordinary Shares
Restricted Share Units 0 Mar 5, 2024 Direct Ordinary Shares

Transactions reported by Mark Sabag for Teva Pharmaceutical Industries Ltd

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.